0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Editorial  | 
The Role of Clozapine in Treatment-Resistant Schizophrenia
John M. Kane, MD; Christoph U. Correll, MD
JAMA Psychiatry
Original Investigation  | 
Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia A Network Meta-analysis
Myrto T. Samara, MD; Markus Dold, MD; Myrsini Gianatsi, MSc; et al.
JAMA Psychiatry
Review  | 
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Nora D. Volkow, MD; James M. Swanson, PhD; A. Eden Evins, MD; et al.
JAMA Psychiatry
Editorial  | 
Deconstructing the Psychosis Risk Syndrome Moving the Field of Prevention Forward
Barbara A. Cornblatt, PhD, MBA; Ricardo E. Carrión, PhD